Yildirim, H.C.; Guven, D.C.; Aktepe, O.H.; Taban, H.; Yilmaz, F.; Yasar, S.; Aksoy, S.; Erman, M.; Kilickap, S.; Yalcin, S.
Blood Based Biomarkers as Predictive Factors for Hyperprogressive Disease. J. Clin. Med. 2022, 11, 5171.
https://doi.org/10.3390/jcm11175171
AMA Style
Yildirim HC, Guven DC, Aktepe OH, Taban H, Yilmaz F, Yasar S, Aksoy S, Erman M, Kilickap S, Yalcin S.
Blood Based Biomarkers as Predictive Factors for Hyperprogressive Disease. Journal of Clinical Medicine. 2022; 11(17):5171.
https://doi.org/10.3390/jcm11175171
Chicago/Turabian Style
Yildirim, Hasan Cagri, Deniz Can Guven, Oktay Halit Aktepe, Hakan Taban, Feride Yilmaz, Serkan Yasar, Sercan Aksoy, Mustafa Erman, Saadettin Kilickap, and Suayib Yalcin.
2022. "Blood Based Biomarkers as Predictive Factors for Hyperprogressive Disease" Journal of Clinical Medicine 11, no. 17: 5171.
https://doi.org/10.3390/jcm11175171
APA Style
Yildirim, H. C., Guven, D. C., Aktepe, O. H., Taban, H., Yilmaz, F., Yasar, S., Aksoy, S., Erman, M., Kilickap, S., & Yalcin, S.
(2022). Blood Based Biomarkers as Predictive Factors for Hyperprogressive Disease. Journal of Clinical Medicine, 11(17), 5171.
https://doi.org/10.3390/jcm11175171
